Here are some sobering numbers, especially for those wandering the halls of the annual BIO gathering that gets under way today in Washington, DC. The pharmaceutical industry spent an estimated $68 million less on drug R&D in 2010, a 3 percent drop from spending during the previous two years, according to data compiled by CMR International.
